Sexual health is one of the most consequential and most consistently neglected dimensions of adult wellness in the United States. The country has seen sustained increases in sexually transmitted infection rates over the past decade, with cases of chlamydia, gonorrhea, and syphilis reaching record highs in recent years. The primary driver of this trend is not a change in behavior alone but a widening gap between who should be receiving regular sexual health screening and who actually does. Closing that gap is one of the most achievable public health opportunities available.
Why the sexual health testing gap is so consequential
The majority of sexually transmitted infections produce no noticeable symptoms in most people who carry them. Chlamydia, gonorrhea, herpes, and human papillomavirus are all capable of being transmitted between partners who have no awareness that they are infectious. This asymptomatic reality means infections circulate silently through communities for months or years, producing health consequences that accumulate long before any symptom prompts a person to seek evaluation.
Untreated chlamydia and gonorrhea are among the leading causes of preventable infertility in the United States, producing inflammation in the reproductive tract that can cause irreversible structural damage before a single symptom is experienced. Untreated syphilis progresses through stages that eventually cause neurological and cardiovascular damage over years of silent development. Human papillomavirus, the most prevalent sexually transmitted infection in the country, is the primary cause of cervical malignancy and is implicated in additional cancers affecting the genitals, anus, and throat.
HIV transmission continues in part because people living with the virus who do not know their status cannot access treatment and cannot be counseled about their transmissibility. People on effective antiretroviral treatment who achieve an undetectable viral load cannot transmit HIV sexually, which means knowing one’s status and accessing care is itself a direct and powerful public health intervention. Sexual health outcomes at the population level are fundamentally shaped by how consistently individuals know their own status.
Who should be tested and how often
Sexual health guidelines recommend annual chlamydia and gonorrhea testing for all sexually active women under 25 and for older women with new or multiple partners. Sexually active men who have sex with men should be tested for HIV, syphilis, chlamydia, and gonorrhea at least annually, and every three to six months if they have multiple partners or other ongoing risk factors. All adults between the ages of 13 and 64 should receive HIV testing at least once, with more frequent testing recommended for those with ongoing exposure risk.
Testing is substantially simpler than most people assume. The majority of STI tests require only a urine sample or a self-collected swab. Many health departments, community health centers, and online services now offer confidential testing without requiring a primary care visit. Home testing kits mailed directly to patients have significantly expanded access for people facing logistical, financial, or stigma-related barriers to clinical sexual health services.
Protecting sexual health proactively
Consistent and correct condom use reduces the risk of most sexually transmitted infections substantially, though it does not eliminate risk entirely for infections spread through skin-to-skin contact including herpes and HPV. Pre-exposure prophylaxis, known as PrEP, reduces HIV acquisition risk by more than 99 percent for people who take it consistently and is recommended for anyone at substantial ongoing exposure risk.
HPV vaccination is recommended through age 26 for everyone not vaccinated during adolescence, with shared decision-making about vaccination between ages 27 and 45 for adults who may still benefit. Hepatitis B vaccination protects against a sexually transmissible infection capable of causing chronic liver disease and liver malignancy over time. Having direct and honest conversations with sexual partners about testing history, current status, and prevention practices is one of the most effective individual-level strategies available for reducing sexual health risk across any relationship configuration.
Regular engagement with sexual health care, including routine testing, open conversations with providers, and consistent use of prevention tools, transforms a reactive response to symptoms into a proactive practice that protects both individual and community wellbeing over the long term.
